Dr. Reddy's Laboratories Ltd (NYSE: RDY), Ransthalam Mandal, Srikakulam, India – FDA Inspections
Inspection records and compliance data for Dr. Reddy's Laboratories Ltd in Ransthalam Mandal, Srikakulam. 3 FDA inspections on record, last inspected November 14, 2025. Publicly traded as NYSE: RDY.
This profile covers Dr. Reddy's Laboratories Ltd based in Ransthalam Mandal, Srikakulam, India.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected April 14, 2017. Last inspected November 14, 2025.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 14, 2025 | Not classified | Human Drugs | 1296480 |
| May 31, 2018 | NAI | Human Drugs · Drug Quality Assurance | 1057947 |
| April 14, 2017 | NAI | Human Drugs · Drug Quality Assurance | 1013800 |
Form 483s (1)
Companies with similar regulatory profiles, compliance history, and operations.
Name
Dr. Reddy's Laboratories Ltd
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3005336882
Address
Unit 1, Cto/Sez Process, Sector No'S. 28 To 34, 36 To 37, 40, 50 To 53 & 03, Survey No' S. 57 To 58, 60, 72 To 73, 76 To 77 & 80, Devunipalavalasa Vill, Ransthalam Mandal, Srikakulam, India
Country
India
ID: d2b12af8-d5d5-41a8-bb7a-b1acef5c5aa2